Search

Pharmaceutical companies charge high prices for branded products, but in most instances the research that results in these drugs is supported financially by the National Institutes of Health (NIH) or [...]

Over the past few decades, retirement savings has shifted from a defined-benefit model to a defined-contribution model. If we look at the major social welfare programs operated by the federal [...]

ABSTRACT The Medicare and Medicaid programs are not serving the needs of their target populations as well as they could. Democrats believe that Medicaid can be improved with more money [...]

The article examines the constitutionality of the U.S. federal court's independent exercise of inherent powers (IP) in multidistrict litigations (MDL) despite the lack of authorization by Congress. Also cited are the claim by the Supreme Court that the Constitution allows the use of IP in the exercise of judicial power under Article III, and the need to ensure the parties' due process rights when exercising IPs.

The article examine the practice of forced fee transfers in Multi-District Litigations (MDLs) and whether the law of restitution and unjust enrichment supports such fee awards. It argues that MDL procedures often violate the law and judges regulate fees more aggressively in MDLs than in other types of litigation. It further highlights that judges in MDLs has the authority to override the contractual entitlements of individually retained plaintiffs attorneys (IRPAs).

I. INTRODUCTION II. THE PSLRA'S MECHANISMS FOR SELECTING THE LEAD PLAINTIFF AND CLASS COUNSEL AND FOR SETTING ATTORNEYS' FEES A. The PSLRA Requires Lead Plaintiffs to 'Select and Retain' Class [...]

Introduction I. Data Description II. Results A. Descriptive Statistics B. Multivariate Analysis 1. Changes in the Rate of Self-Representation over Time 2. Claim-level Factors a. Claim Size b. Claim Complexity [...]

This Article uses three recent multi-district litigations ('MDLs') that produced massive settlements--Guidant ($240 million), Vioxx ($4.85 billion), and Zyprexa ($700 million)--to study the emerging quasi-class action approach to MDL management. [...]

THE UNITED STATES IS CURRENTLY IN THE midst of its third medical malpractice crisis in 30 years. The story is all too familiar: Insurance premiums spike, prompting demoralized doctors to [...]

(June 6, 2019), https://www.kff.org/medicare /fact-sheet/medicare-advantage/#:~:text=Medicare%20Advantage%20Enrollment,Advantage%20plans%20(Figure%201) ("In 2019, the majority of the 64 million people on Medicare are covered by traditional Medicare, but one-third (34%) are enrolled in Medicare Advantage plans."). In addition, we note the incoherence of the claim made by M4A proponents that Medicare does not incur expenditures like marketing and the payment of profits - when the reality is that those expenditures are a standard feature of Medicare Advantage plans. D. M4A will Lower Health Care Spending M4A's proponents argue incessantly that Medicare spends less than private insurance to purchase the same services - and imply that it will be a straightforward step to impose those prices on providers once everyone is enrolled in M4A. B. M4A is Popular A significant part of the appeal of M4A is its supposed popularity. [Extracted from the article]